Vitamin B12

Verify with FDA CVM →

661 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
661
Total Reports
153
Deaths Reported
2310.0%
Death Rate

Active Ingredients

Vitamin B12

Administration Routes

UnknownSubcutaneousParenteralOralIntravenousOtherIntramuscularCutaneousOphthalmicIntraocular

Species Affected

Cat 322
Dog 320
Human 13
Pig 3
Cattle 2
Horse 1

Most Affected Breeds

Domestic Shorthair 184
Retriever - Labrador 42
Domestic Mediumhair 34
Shepherd Dog - German 28
Domestic Longhair 25
Chihuahua 21
Unknown 13
Siamese 13
Cat (unknown) 12
Retriever - Golden 11

Most Reported Reactions

Vomiting 134
Lethargy (see also Central nervous system depression in 'Neurological') 103
Diarrhoea 101
Weight loss 96
Anorexia 88
Death by euthanasia 86
Other abnormal test result NOS 73
Not eating 69
Lethargy (see also Central nervous system depression in Neurological) 67
Lack of efficacy - NOS 66
Death 60
Ataxia 57

Outcome Breakdown

Ongoing
259 (38.7%)
Outcome Unknown
142 (21.2%)
Recovered/Normal
105 (15.7%)
Euthanized
87 (13.0%)
Died
68 (10.2%)
Recovered with Sequela
8 (1.2%)

Data Summary

Metric Value
Total adverse event reports 661
Reports involving death 153
Case-fatality rate (reported events) 2310.0%
Distinct species in reports 6
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Vitamin B12 Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 661 adverse event reports referencing Vitamin B12, including 153 reports in which the animal died — a 2310.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Vitamin B12. Reported administration routes include Unknown, Subcutaneous, Parenteral, Oral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Vitamin B12 reports are Cat (322 reports), Dog (320 reports), Human (13 reports), with Cat accounting for the largest share. Within those species, Domestic Shorthair (184), Retriever - Labrador (42), Domestic Mediumhair (34) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Vitamin B12 are Vomiting (134), Lethargy (see also Central nervous system depression in 'Neurological') (103), Diarrhoea (101), Weight loss (96). Of the 669 reports with a coded outcome, Ongoing is the leading category at 38.7%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Vitamin B12.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial